Jing Zhen
Impact in
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
- Pharmacology top 5%
- Hibiscus Plant Research Studies
Papers in
-
- Cancer-related molecular mechanisms research 5
- Cancer, Lipids, and Metabolism 3
- MicroRNA in disease regulation 2
-
- Protein purification and stability 4
- RNA modifications and cancer 4
- Ubiquitin and proteasome pathways 3
- Co-authors
- Qingli Wu (6 shared papers)James Edward Simon (5 shared papers)Yue Guo (2 shared papers)Yadong Qi (1 shared paper)Thomas S. Villani (1 shared paper)Chi‐Tang Ho (1 shared paper)Min‐Hsiung Pan (1 shared paper)Pengbo Wen (1 shared paper)
- Journals
- Aging (5 papers)Journal of the American Society for Mass Spectrometry (2 papers)Cell Biology and Toxicology (2 papers)Food Chemistry (1 paper)Molecules (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Jing Zhen
46 papers receiving 1.1k citations
Jing Zhen's Hit Papers
Peers
Comparison fields: 5 of 120
- Biochemistry 111
- Pharmacology 124
- Microbiology 8
- Cancer Research 90
- Molecular Biology 442
Countries citing papers authored by Jing Zhen
This map shows the geographic impact of Jing Zhen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Zhen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Zhen more than expected).
Fields of papers citing papers by Jing Zhen
This network shows the impact of papers produced by Jing Zhen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Zhen. The network helps show where Jing Zhen may publish in the future.
Co-authors
The 25 scholars most cited alongside Jing Zhen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 186 | |
| 2 | The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases Hit paper breakdown → | 2023 | 153 |
| 3 | 2014 | 80 | |
| 4 | 2017 | 57 | |
| 5 | 2020 | 48 | |
| 6 | 2021 | 38 | |
| 7 | 2017 | 36 | |
| 8 | 2010 | 34 | |
| 9 | 2015 | 34 | |
| 10 | 2020 | 34 | |
| 11 | 2019 | 32 | |
| 12 | 2020 | 32 | |
| 13 | 2023 | 26 | |
| 14 | 2021 | 23 | |
| 15 | 2022 | 23 | |
| 16 | 2018 | 20 | |
| 17 | 2020 | 17 | |
| 18 | 2018 | 14 | |
| 19 | Deubiquitinase ZRANB1 drives hepatocellular carcinoma progression through SP1-LOXL2 axis. | 2021 | 14 |
| 20 | 2021 | 14 |
About Jing Zhen
Jing Zhen is a scholar working on Cancer Research, Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), Protein purification and stability (4 papers), RNA modifications and cancer (4 papers), Ferroptosis and cancer prognosis (4 papers), Cancer, Lipids, and Metabolism (3 papers), Ubiquitin and proteasome pathways (3 papers), Natural Antidiabetic Agents Studies (3 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Biochemistry (111 citations), Pharmacology (124 citations), Microbiology (8 citations), Cancer Research (90 citations) and Molecular Biology (442 citations). Jing Zhen has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Qingli Wu, James Edward Simon, Yue Guo, Yadong Qi, Thomas S. Villani, Chi‐Tang Ho, Min‐Hsiung Pan, Pengbo Wen, Lei Xiao and Xin Liu. Their work appears in journals such as Aging, Journal of the American Society for Mass Spectrometry, Cell Biology and Toxicology, Food Chemistry and Molecules.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.